Form 8-K - Current report:
SEC Accession No. 0001193125-16-584809
Filing Date
2016-05-10
Accepted
2016-05-10 08:39:11
Documents
8
Period of Report
2016-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d148286d8k.htm 8-K 23944
2 EX-4.1 d148286dex41.htm EX-4.1 76161
3 EX-4.2 d148286dex42.htm EX-4.2 74376
4 EX-5.1 d148286dex51.htm EX-5.1 15047
5 EX-99.1 d148286dex991.htm EX-99.1 171893
6 EX-99.2 d148286dex992.htm EX-99.2 34858
7 GRAPHIC g148286snap2.jpg GRAPHIC 7448
8 GRAPHIC g148286snap3.jpg GRAPHIC 10549
  Complete submission text file 0001193125-16-584809.txt   422443
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 161633827
SIC: 2834 Pharmaceutical Preparations